Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.19.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Entity Information [Line Items]    
Cash in excess of FDIC limits $ 12,721  
Concentration risk percentage for accounts receivable, revenue and inventory 0.00% 0.00%
Cash equivalents $ 0 $ 0
Unrestricted control of restricted cash received during the period $ 450  
Maximum length of time credit card processor can withhold a cash reserve balance from the Company 270 days  
Restricted cash $ 251 779
Threshold for determining delinquent accounts receivable 30 days  
Allowance for doubtful accounts $ 200 200
Impairment of long-lived assets 0 0
Impairment of intangible assets 0 0
Matching contribution to 401(k) plan 83  
Research and development 1,885 724
Advertising costs 907 380
Liability for unrecognized tax uncertainties 0 0
Consumer Products [Member]    
Entity Information [Line Items]    
Research and development 1,008 251
Specialty Pharmaceuticals [Member]    
Entity Information [Line Items]    
Research and development 877 473
Shipping and Handling [Member]    
Entity Information [Line Items]    
Cost of Goods and Services Sold 1,958 854
Revenue $ 396 $ 230
Restricted Stock Units (RSUs) [Member]    
Entity Information [Line Items]    
Vesting percent at date of grant (percent) 100.00%  
Equity Option [Member]    
Entity Information [Line Items]    
Stock option, maximum term 10 years  
Minimum [Member] | Equity Option [Member]    
Entity Information [Line Items]    
Award vesting period 2 years  
Maximum [Member] | Equity Option [Member]    
Entity Information [Line Items]    
Award vesting period 4 years  
CannaVest Europe, GmbH [Member]    
Entity Information [Line Items]    
Ownership interest (percent) 70.00%